−0.100CAD
−1.99 MCAD
17.52 MCAD
17.61 M
About CRESCITA THERAPEUTICS INC
Sector
CEO
Serge Verreault
Headquarters
Laval
Website
Founded
2016
ISIN
CA2258471028
FIGI
BBG008HJRV31
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. Its products include Pliaglis, Alyria, Laboratoire Dr Renaud, and Pro-Derm. It operates through the following business segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells non-prescription skincare products. The Licensing and Royalties segment refers to the licensing related to its prescription product. The Manufacturing and Services segment relates to the sale of topical products and product development services. The company was founded on March 1, 2016 and is headquartered in Laval, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CTX is 0.45 CAD — it has increased by 12.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange CRESCITA THERAPEUTICS INC stocks are traded under the ticker CTX.
Yes, you can track CRESCITA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, CTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRESCITA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CRESCITA THERAPEUTICS INC EBITDA is −450.00 K CAD, and current EBITDA margin is −2.57%. See more stats in CRESCITA THERAPEUTICS INC financial statements.